New York, New York (PRWEB) April 25, 2012
Bernstein Liebhard LLP is pleased to announce that on April 13, 2012 partner Jeffrey S. Grand was named to the Plaintiffs’ Steering Committee (“PSC”) in the following actions: In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation (“MDL No. 2187”); In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326”); and In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation (“MDL No. 2327”) by Chief Judge Joseph R. Goodwin.* All of the federal transvaginal mesh MDLs are currently underway in the U.S. District Court for the Southern District of West Virginia. As described in the orders, Judge Goodwin approved a singular PSC to coordinate across all four transvaginal mesh MDLs pending before the court.
As a member of the PSC in each transvaginal mesh MDL, Mr. Grand will assist in leading and coordinating the litigations against these manufacturers on behalf of individuals who were allegedly injured as a result of having undergone surgical placement of vaginal mesh. In response to receiving this appointment, Mr. Grand commented “We look forward to working with the other attorneys on the PSC and moving this litigation forward on behalf of all those injured by defective vaginal mesh implants.”
Previously, on July 26, 2011, Mr. Grand was named Co-Liaison Counsel in In re Pelvic Mesh/Gynecare Litigation, No. 6341-10 (N.J. Super Ct.), and In re Pelvic Mesh Litigation/Bard No. L-6339-10 (N.J. Super. Ct.), which are two consolidated actions of all the vaginal mesh lawsuits filed in New Jersey state court. These state court actions are pending before the Honorable Carol E. Higbee in the Superior Court of New Jersey Law Division, Atlantic County.
Mr. Grand’s most recent appointment follows his extensive experience in other high-profile cases involving defective medical devices and dangerous drugs including Vioxx, Fosamax and Yaz. He has supervised the day-to-day management of complex, multi-party mass tort litigation in state and federal courts and multi-district litigation throughout the United States, and has served on discovery and administrative committees in these litigations. He has served as a member of the trial teams that obtained a $47.5 million verdict for Vioxx-related cardiovascular injury in Humeston v. Merck & Co., in New Jersey Superior Court in 2007, and several plaintiff victories in the Chinese-Manufactured Drywall Products Liability Litigation in the United States District Court, Eastern District of Louisiana.
Federal Transvaginal Mesh MDL And State Vaginal Mesh Litigation Involve Similar Claims
The four transvaginal mesh MDL actions pending in federal court involve similar allegations against pelvic mesh litigation manufacturers C.R. Bard, American Medical Systems, Boston Scientific and Ethicon. Similar to the New Jersey state court actions, plaintiffs filing lawsuits in the federal transvaginal mesh MDLs allege that these manufacturers produced and sold defective vaginal mesh products, which are used to treat pelvic organ prolapse and stress urinary incontinence.
In 2008, the U.S. Food and Drug Administration issued its first communication regarding the dangers associated with vaginal mesh, and has since continued to review the safety of the devices. Since that time, Bernstein Liebhard LLP has provided a wealth of consumer information concerning vaginal mesh on its website, http://www.consumerinjurylawyers.com. Those who have experienced transvaginal mesh complications may be entitled to compensation for medical expenses, pain and suffering, lost wages and other injuries.
For more information about filing a vaginal mesh lawsuit, contact an attorney at Bernstein Liebhard LLP at (877) 779-1414 or at info(at)consumerinjurylawyers(dot)com. Our lawyers and staff understand the sensitive nature of the complications caused by vaginal mesh and will answer your questions in a caring and sympathetic manner.
*wvsd.uscourts.gov/MDL/2187/pdfs/PTO_33.pdf; wvsd.uscourts.gov/MDL/amsinc/pdfs/PTO_4.pdf; wvsd.uscourts.gov/MDL/boston/pdfs/PTO_4.pdf; and wvsd.uscourts.gov/MDL/ethicon/pdfs/PTO_4.pdf.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP